肾移植病人因术后使用免疫抑制剂而致免疫功能低下,巨细胞病毒(CMV)活动性感染发生率很高。达50～70％。肾移植术后CMV感染者死亡率达25％,CMV肺炎患者死亡率高达50％。可见CMV感染是肾移植术后十分常见而严重的感染。 随着肾移植的普遍开展,我国每年肾移植例数逐年上升,由于肾移植术后CMV感染诊断方法的进展及特异性抗CMV药物的问世,肾移植术后 Kidney transplant patients due to postoperative immunosuppressive agents caused by immunocompromised, cytomegalovirus (CMV) active infection is very high. Up to 50 ~ 70%. Mortality after CMV infection in renal transplant recipients is 25% and mortality in CMV pneumonia is as high as 50%. CMV infection can be seen after transplantation is a very common and serious infection. With the common development of kidney transplantation, the number of renal transplant cases in our country increases year by year. Due to the progress of diagnosis of CMV infection after kidney transplantation and the advent of specific anti-CMV drugs,